MADISON, Wis.--(BUSINESS WIRE)--May 1, 2024--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.
-
BofA Securities Health Care Conference, Las Vegas
Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20240501269699/en/
Nathan Harrill
Exact Sciences Corp.
investorrelations@exactsciences.com
608-535-8659
Source: Exact Sciences Corp.
